AC
CVS icon

Abbrea Capital’s CVS Health CVS Stock Holding History

Abbrea Capital’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$294K Sell
4,981
-758
-13% -$47.4K 0.04% 189
2024
Q1 		$458K Sell
5,739
-255
-4% -$19.5K 0.06% 169
2023
Q4 		$473K Sell
5,994
-885
-13% -$63K 0.07% 161
2023
Q3 		$480K Sell
6,879
-679
-9% -$48.1K 0.08% 156
2023
Q2 		$523K Sell
7,558
-160
-2% -$11.4K 0.08% 154
2023
Q1 		$574K Sell
7,718
-20
-0.3% -$1.68K 0.1% 141
2022
Q4 		$721K Sell
7,738
-10
-0.1% -$965 0.13% 125
2022
Q3 		$739K Sell
7,748
-539
-7% -$53.4K 0.14% 120
2022
Q2 		$768K Hold
8,287
– – 0.13% 127
2022
Q1 		$839K Buy
8,287
+100
+1% +$10.5K 0.12% 135
2021
Q4 		$845K Buy
8,187
+390
+5% +$36K 0.11% 142
2021
Q3 		$662K Buy
7,797
+100
+1% +$8.38K 0.1% 148
2021
Q2 		$642K Buy
7,697
+950
+14% +$77.8K 0.1% 147
2021
Q1 		$508K Buy
6,747
+401
+6% +$29.2K 0.08% 151
2020
Q4 		$433K Buy
6,346
+243
+4% +$15.8K 0.08% 156
2020
Q3 		$356K Sell
6,103
-477
-7% -$29.7K 0.08% 146
2020
Q2 		$428K Buy
6,580
+382
+6% +$24.1K 0.1% 141
2020
Q1 		$368K Buy
6,198
+159
+3% +$10.6K 0.1% 138
2019
Q4 		$449K Buy
6,039
+24
+0.4% +$1.69K 0.1% 138
2019
Q3 		$379K Sell
6,015
-128
-2% -$7.58K 0.09% 144
2019
Q2 		$335K Buy
+6,143
New +$331K 0.08% 150
2019
Q1 		– Sell
-4,151
Closed -$272K – 170
2018
Q4 		$272K Hold
4,151
– – 0.09% 144
2018
Q3 		$327K Buy
4,151
+245
+6% +$17.5K 0.1% 140
2018
Q2 		$251K Sell
3,906
-199
-5% -$13.1K 0.08% 153
2018
Q1 		$255K Buy
4,105
+324
+9% +$23.2K 0.08% 152
2017
Q4 		$274K Buy
3,781
+409
+12% +$29.7K 0.09% 138
2017
Q3 		$274K Buy
3,372
+10
+0.3% +$791 0.1% 135
2017
Q2 		$271K Sell
3,362
-398
-11% -$31.4K 0.11% 132
2017
Q1 		$295K Sell
3,760
-246
-6% -$19.6K 0.12% 122
2016
Q4 		$316K Buy
+4,006
New +$324K 0.15% 114

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Abbrea Capital's CVS Position: Q2 2024 in Review

Abbrea Capital reduced its CVS Health (CVS) stake by 13% in Q2 2024, selling an estimated $47.4K and leaving 4,981 shares worth $294K. The position accounts for 0.04% of the portfolio, ranked #189.

Abbrea Capital first reported a position in CVS in Q4 2016 and has held it in 30 quarters since. The position peaked at $845K in Q4 2021. 1,911 funds tracked by Wall St. Rank hold CVS as of Q2 2024.

  • Abbrea Capital held 4,981 shares of CVS Health worth $294K as of Q2 2024.
  • Abbrea Capital sold 758 CVS Health shares in Q2 2024, an estimated $47.4K.
  • CVS Health made up 0.04% of Abbrea Capital's portfolio in Q2 2024, its #189 holding.
  • Abbrea Capital first reported a position in CVS Health in Q4 2016 and has held it in 30 quarters since.
  • Abbrea Capital's CVS Health position peaked at $845K in Q4 2021.
  • 1,911 funds tracked by Wall St. Rank held CVS Health as of Q2 2024.

Based on Abbrea Capital's 13F filing for Q2 2024, filed 8 Aug 2024.